ArticleLeukemia research reports2022

Daratumumab as a Frontline Immunosuppression for Pure Red Cell Aplasia after Major ABO-mismatched Allogeneic Hematopoietic Stem Cell Transplantation.

Thiti Asawapanumas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.